Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
Dow
Mallinckrodt
Baxter

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

PREPOPIK Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Prepopik, and when can generic versions of Prepopik launch?

Prepopik is a drug marketed by Ferring Pharms Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has thirty-one patent family members in twenty-four countries.

The generic ingredient in PREPOPIK is citric acid; magnesium oxide; sodium picosulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the citric acid; magnesium oxide; sodium picosulfate profile page.

Drug patent expirations by year for PREPOPIK
Drug Prices for PREPOPIK

See drug prices for PREPOPIK

Drug Sales Revenue Trends for PREPOPIK

See drug sales revenues for PREPOPIK

Recent Clinical Trials for PREPOPIK

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ferring PharmaceuticalsPhase 4
The Cleveland ClinicPhase 4
Ferring PharmaceuticalsPhase 3

See all PREPOPIK clinical trials

Recent Litigation for PREPOPIK

Identify potential future generic entrants

District Court Litigation
Case NameDate
Ferring Pharmaceuticals Inc. v. Novel Laboratories, Inc.2017-07-05
Ferring Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.2017-04-19
Ferring Pharmaceuticals Inc. v. Par Pharmaceutical Inc.2015-02-20

See all PREPOPIK litigation

Synonyms for PREPOPIK
Citric acid / magnesium oxide / sodium picosulfate
Citric acid mixture with magnesium oxide and sodium picosulfate
Clenpiq
S900007380

US Patents and Regulatory Information for PREPOPIK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc PREPOPIK citric acid; magnesium oxide; sodium picosulfate FOR SOLUTION;ORAL 202535-001 Jul 16, 2012 RX Yes Yes   See Pricing   See Pricing Y   See Pricing
Ferring Pharms Inc PREPOPIK citric acid; magnesium oxide; sodium picosulfate FOR SOLUTION;ORAL 202535-001 Jul 16, 2012 RX Yes Yes   See Pricing   See Pricing Y   See Pricing
Ferring Pharms Inc PREPOPIK citric acid; magnesium oxide; sodium picosulfate FOR SOLUTION;ORAL 202535-001 Jul 16, 2012 RX Yes Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for PREPOPIK
Drugname Dosage Strength RLD Date
➤ Subscribe Oral Solution 10 mg, 3.5 g, and 12 g ➤ Subscribe   See Pricing

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Dow
Express Scripts
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.